ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
4 announcements with these filters
Strides Pharma Science Ltd reported revenue from operations of ₹1,265 Cr (+13.0% YoY) and net profit of ₹165.5 Cr (+56.7% YoY) for Q1 FY27.
Strides Pharma Science Ltd reported revenue from operations of ₹1,324 Cr (+11.2% YoY) and net profit of ₹129.3 Cr (+51.1% YoY) for Q4 FY26.
Strides Pharma reported audited FY26 results and recommended a 50% final dividend. The proposed payout will result in an approximate cash outflow of ₹46.10 Crore.
Strides Pharma Science Ltd reported net profit of ₹208 Cr (+131.1% YoY) for Q3 FY26.